4-Aminopyridine activates calcium influx through modulation of the pore-forming purinergic receptor in human peripheral blood mononuclear cells

Canadian Journal of Physiology and Pharmacology

Volumn 82, Issue 1, 2004, Pages 50-56

  Lajdova, Ingrid ^a   Chorvat Jr , Dusan ^b   Spustova, Viera ^a   Chorvatova, Alzbeta ^a,b,c  

^a INST OF PREV AND CLINICAL MEDICINE   (Slovakia)

^b INTERNATIONAL LASER CENTER   (Slovakia)

^c UNIVERSITY OF MONTREAL   (Canada)

Author keywords

4 aminopyridine; Calcium; Human lymphocytes; Purinergic receptors

Indexed keywords

1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; 4 AMINOPYRIDINE; ADENOSINE TRIPHOSPHATE; BRILLIANT BLUE; ETHIDIUM BROMIDE; NICKEL; PROPIDIUM IODIDE; PURINE P2X7 RECEPTOR; PURINE RECEPTOR; THAPSIGARGIN;

ARTICLE; BLOOD SAMPLING; CALCIUM TRANSPORT; CALIBRATION; CELL COMPARTMENTALIZATION; CELL ISOLATION; CELL POPULATION; CONTROLLED STUDY; EXTRACELLULAR CALCIUM; HUMAN; HUMAN CELL; MODULATION; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; POROSITY; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

4-AMINOPYRIDINE; ANALYSIS OF VARIANCE; CALCIUM SIGNALING; HUMANS; INTRACELLULAR FLUID; LEUKOCYTES, MONONUCLEAR; RECEPTORS, PURINERGIC;

EID: 1842559520     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y03-128     Document Type: Article

References (31)

1. 2+ triggered by 4-aminopyridine in Jurkat T lymphocytes. Biochim. Biophys. Acta, 1622: 89-98.
2. Baricordi, O.R., Ferrari, D., Melchiorri, L., Chiozzi, P., Hanau, S., Chiari, E., Rubini, M., and Di Virgilio, F. 1996. An ATP-activated channel is involved in mitogenic stimulation of human T lymphocytes. Blood, 87: 682-690.
3. Berridge, M.J. 1995a. Calcium signalling and cell proliferation. Bioessays, 17: 491-500.
4. Berridge, M.J. 1995b. Inositol trisphosphate and calcium signaling. Ann. N.Y. Acad. Sci. 766: 31-43.
5. Bever, C.T., Jr. 1994. The current status of studies of aminopyridines in patients with multiple sclerosis. Ann. Neurol. 36(Suppl.): S118-S121.
6. Cabado, A.G., Alfonso, A., Vieytes, M.R., Gonzalez, M., Botana, M.A., and Botana, L.M. 2000. Crosstalk between cytosolic pH and intracellular calcium in human lymphocytes: effect of 4-aminopyridin, ammoniun chloride and ionomycin. Cell Signal. 12: 573-581.
7. Di Virgilio, F., Chiozzi, P., Ferrari, D., Falzoni, S., Sanz, J.M., Morelli, A., Torboli, M., Bolognesi, G., and Baricordi, O.R. 2001. Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood, 97: 587-600.
8. Dubyak, G.R., and el Moatassim, C. 1993. Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am. J. Physiol. 265: C577-C606.
9. + currents in the human Jurkat T cell line: effects of phytohaemagglutinin. J. Physiol. 412: 135-154.
10. Gargett, C.E., and Wiley, J.S. 1997. The isoquinoline derivative KN-62 a potent antagonist of the P2Z-receptor of human lymphocytes. Br. J. Pharmacol. 120: 1483-1490.
11. Gargett, C.E., Cornish, J.E., and Wiley, J.S. 1997. ATP, a partial agonist for the P2Z receptor of human lymphocytes. Br. J. Pharmacol. 122: 911-917.
12. + channels in human leukemic T cells. J. Gen. Physiol. 99: 63-84.
13. 2+ entry induced by rapid cytosolic alkalinization in Jurkat T-lymphocytes. Biochem. J. 301(Pt 1): 83-88.
14. Hoth, M., and Penner, R. 1992. Depletion of intracellular calcium stores activates a calcium current in mast cells. Nature (London), 355: 353-356.
15. 7 receptors. Mol. Pharmacol. 58: 82-88.
16. 2+] with fluorescent indicators. Methods Cell Biol. 40: 155-181.
17. Kerschbaum, H.H., and Cahalan, M.D. 1998. Monovalent permeability, rectification, and ionic block of store-operated calcium channels in Jurkat T lymphocytes. J. Gen. Physiol. 111: 521-537.
18. 2+ channel in Jurkat T lymphocytes. Science (Washington, D.C.), 283: 836-839.
19. + channel blocker, in HepG2 human hepatoblastoma cells. Pharmacology, 60: 74-81.
20. Markwardt, F., Lohn, M., Bohm, T., and Klapperstuck, M. 1997. Purinoceptor-operated cationic channels in human B lymphocytes. J. Physiol. 498(Pt. 1): 143-151.
21. Putney, J.W., Jr., and McKay, R.R. 1999. Capacitative calcium entry channels. Bioessays, 21: 38-46.
22. Rassendren, F., Buell, G.N., Virginio, C., Collo, G., North, R.A., and Surprenant, A. 1997. The permeabilizing ATP receptor, P2X7. Cloning and expression of a human cDNA. J. Biol. Chem. 272: 5482-5486.
23. Solari, A., Uitdehaag, B., Giuliani, G., Pucci, E., and Taus, C. 2001. Aminopyridines for symptomatic treatment in multiple sclerosis. The Cochrane Library, Issue 4. John Wiley and Sons, Ltd., Chichester, U.K. Cochrane Database Syst. Rev. CD001330.
24. Surprenant, A., Rassendren, F., Kawashima, E., North, R.A., and Buell, G. 1996. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science (Washington, D.C.), 272: 735-738.
25. Virginio, C., MacKenzie, A., North, R.A., and Surprenant, A. 1999. Kinetics of cell lysis, dye uptake and permeability changes in cells expressing the rat P2X7 receptor. J. Physiol. 519(Pt. 2): 335-346.
26. Vulchanova, L., Arvidsson, U., Riedl, M., Wang, J., Buell, G., Surprenant, A., North, R.A., and Elde, R. 1996. Differential distribution of two ATP-gated channels (P2X receptors) determined by immunocytochemistry. Proc. Natl. Acad. Sci. U.S.A. 93: 8063-8067.
27. Vulchanova, L., Riedl, M.S., Shuster, S.J., Buell, G., Surprenant, A., North, R.A., and Elde, R. 1997. Immunohistochemical study of the P2X2 and P2X3 receptor subunits in rat and monkey sensory neurons and their central terminals. Neuropharmacology, 36: 1229-1242.
28. + uptake: inhibition of fluxes by suramin. Arch. Biochem. Biophys. 305: 54-60.
29. Wiley, J.S., Chen, J.R., Snook, M.B., and Jamieson, G.P. 1994. The P2Z-purinoceptor of human lymphocytes: actions of nucleotide agonists and irreversible inhibition by oxidized ATP. Br. J. Pharmacol. 112: 946-950.
30. Zheng, L.M., Zychlinsky, A., Liu, C.C., Ojcius, D.M., and Young, J.D. 1991. Extracellular ATP as a trigger for apoptosis or programmed cell death. J. Cell Biol. 112: 279-288.
31. 2+ stores. Proc. Natl. Acad. Sci. U.S.A. 90: 6295-6299.